Amy Prawira
Impact in
- Otorhinolaryngology top 5%
- Head and Neck Cancer Studies
- Oncology top 10%
- Cancer Immunotherapy and Biomarkers
- Cancer-related Molecular Pathways
- Lung Cancer Research Studies
Papers in
-
- Head and Neck Cancer Studies 5
- Oncology 27
- Cancer Immunotherapy and Biomarkers 12
- PARP inhibition in cancer therapy 6
- Pancreatic and Hepatic Oncology Research 5
- Colorectal Cancer Treatments and Studies 4
- Cancer Cells and Metastasis 3
- Peptidase Inhibition and Analysis 3
- Co-authors
- Andrew H. KayeMichael L. WongChristopher M. HovensLillian L. SiuAaron R. HansenMathew GeorgeFilippo de BraudSarina A. Piha‐Paul
- Journals
- Annals of Oncology (8 papers)Journal of Clinical Oncology (8 papers)Cancer Research (3 papers)British Journal of Cancer (2 papers)Cancer (1 paper)
- Partner nations
- CanadaAustraliaUnited States
In The Last Decade
Amy Prawira
36 papers receiving 611 citations
Peers
Comparison fields: 5 of 74
- Otorhinolaryngology 55
- Oncology 326
- Endocrinology, Diabetes and Metabolism 134
- Cancer Research 111
- Genetics 48
Countries citing papers authored by Amy Prawira
This map shows the geographic impact of Amy Prawira's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Amy Prawira with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Amy Prawira more than expected).
Fields of papers citing papers by Amy Prawira
This network shows the impact of papers produced by Amy Prawira. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Amy Prawira. The network helps show where Amy Prawira may publish in the future.
Co-authors
The 25 scholars most cited alongside Amy Prawira, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2024 | 1 | |
| 2 | 2023 | 4 | |
| 3 | 2023 | 4 | |
| 4 | 2020 | 1 | |
| 5 | 2020 | 32 | |
| 6 | 2020 | 8 | |
| 7 | 2020 | 2 | |
| 8 | A Phase 1 study of AK104, a tetrameric bispecific antibody that targets PD-1 and CTLA-4 in patients with advanced solid tumors | 2019 | 3 |
| 9 | 2019 | 148 | |
| 10 | 2018 | 61 | |
| 11 | 2017 | 6 | |
| 12 | 2017 | 16 | |
| 13 | 2017 | 75 | |
| 14 | 2017 | 1 | |
| 15 | 2016 | 2 | |
| 16 | 2016 | 5 | |
| 17 | 2016 | 0 | |
| 18 | 2016 | 8 | |
| 19 | 2015 | 12 | |
| 20 | 2009 | 91 |
About Amy Prawira
Amy Prawira is a scholar working on Otorhinolaryngology, Oncology, Dermatology, Pulmonary and Respiratory Medicine and Cancer Research, having authored 38 papers that have together received 621 indexed citations. Recurring topics across this work include Cancer Immunotherapy and Biomarkers (12 papers), PARP inhibition in cancer therapy (6 papers), Pancreatic and Hepatic Oncology Research (5 papers), Head and Neck Cancer Studies (5 papers), Lung Cancer Treatments and Mutations (4 papers), Colorectal Cancer Treatments and Studies (4 papers), Cancer Cells and Metastasis (3 papers) and Peptidase Inhibition and Analysis (3 papers). The work is most often cited by research in Otorhinolaryngology (55 citations), Oncology (326 citations), Endocrinology, Diabetes and Metabolism (134 citations), Cancer Research (111 citations) and Genetics (48 citations). Amy Prawira has collaborated with scholars based in Canada, Australia and United States. Frequent co-authors include Andrew H. Kaye, Michael L. Wong, Christopher M. Hovens, Lillian L. Siu, Aaron R. Hansen, Mathew George, Filippo de Braud, Sarina A. Piha‐Paul, Toshihiko Doi and Pradeep Thanigaimani. Their work appears in journals such as Annals of Oncology, Journal of Clinical Oncology, Cancer Research, British Journal of Cancer and Cancer.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.